| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 548202000 | Plural double bonds between ring members of thiazole ring | 26 |
| 20100016608 | LIGHT-ACTIVATED ACTUATOR ELEMENT - Disclosed is light-driven actuator element characterized in that, inter alia, it can be reduced to micrometer size, is rapidly responsive, and reversibly changes to enable repeated use. The light-driven actuator element includes a crystal of diarylethene compound which changes shape upon photoisomerization (e.g., the compound of Structural Formula (I) below, where R | 01-21-2010 |
| 20110054185 | PROCESS FOR PRODUCING THIAZOLE COMPOUND - A process for producing a thiazole compound of the formula (3): | 03-03-2011 |
| 20110306772 | PROCESS FOR THE PREPARATION OF 2-CHLORO-5-CHLOROMETHYL-THIAZOLE - The invention relates to a process for the preparation of 2-chloro-5-chloromethyl-thiazole, which is employed as intermediate in the preparation of compounds having a pesticidal action, which process comprises reacting a compound of formula (II), in free form or in salt form, (III), (IV), (V) or (VI) with a chlorinating agent, where R and M | 12-15-2011 |
| 20160093807 | FULLERENE DERIVATIVE AND N-TYPE SEMICONDUCTOR MATERIAL - The present invention is a material that exhibits excellent properties as an n-type semiconductor, in particular for use in organic thin-film solar cells. The present invention relates to a fullerene derivative represented by formula (1): | 03-31-2016 |
| 548203000 | Chalcogen attached indirectly to the thiazole ring by nonionic bonding | 22 |
| 20090018342 | NEW EPOTHIOLONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR PHARMACEUTICAL USE - This invention relates to the new epothilone derivatives of general formula I, | 01-15-2009 |
| 20090326239 | FERMENTATIVE PREPARATION PROCESS FOR AND CRYSTAL FORMS OF CYTOSTATICS - The invention relates to a new process for concentrating epothilones in culture media, a new process for the production of epothilones, a new process for separating epothilones A and B and a new strain obtained by mutagenesis for the production of epothilones, as well as aspects related thereto. New crystal forms of epothilone B are also described. | 12-31-2009 |
| 20130197236 | Novel Heterocyclic Alkanol Derivatives - The present invention relates to novel heterocyclic alkanol derivatives, to processes for preparing these compounds, to compositions comprising these compounds and to their use as biologically active compounds, in particular for controlling harmful microorganisms in crop protection and in the protection of materials and as plant growth regulators. | 08-01-2013 |
| 548204000 | The chalcogen, X, is in a -C(=X)- group | 14 |
| 20080242869 | Tri(Cyclo) Substituted Amide Compounds - Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 10-02-2008 |
| 20090118516 | Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same - The present invention provides a process for preparing thiazole derivatives of formula (I), that activate the delta subtype of the human Peroxisome Proliferator Activated Receptor (hPPAR δ), and also provides compounds of formula (II), (IV), (X), (XI) and (XII), intermediate compounds for preparation of the above compounds of formula (I). | 05-07-2009 |
| 20090306396 | NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I): | 12-10-2009 |
| 20090312556 | N-(2-AMINIPHENYL)-4-(5-((ETHYLAMINO)METHYL)-1,2-THIAZOL-2-YL) BENZAMIDE AND N-(2-AMINOPHENYL)-4-(5-((ISOPROPYLAMINO)METHYL)-1,2-THIAZOL-2-YL) BENZAMIDE AS HDAC INHIBITORS - The invention concerns novel benzamide compounds of Formula (I): wherein R wherein is ethyl or isopropyl; or a pharmaceutically acceptable salt or pro-drug form thereof. The invention also concerns processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions, which are sensitive to the inhibition of histone deacetylase (HDAC). | 12-17-2009 |
| 20100099885 | PROCESS FOR THE PREPARATION OF FORM I AND FORM II OF RITONAVIR - The present invention relates to processes for the preparation of Form I and Form II of Ritonavir, wherein no seed crystals are used. | 04-22-2010 |
| 20110184186 | PROCESS FOR PREPARING LIGANDS OF PPARDELTA AND THE INTERMEDIATE COMPOUNDS FOR PREPARING THE SAME - The present invention provides a process for preparing thiazole derivatives of formula (I), that activate the delta subtype of the human Peroxisome Proliferator Activated Receptor (hPPAR δ), and also provides compounds of formula (II), (IV), (X), (XI) and (XII), intermediate compounds for preparation of the above compounds of formula (I). | 07-28-2011 |
| 20120197024 | Thiazole Compound (as PPAR delta) Ligand and Pharmaceutical, Cosmetic and Health Food Comprised Thereof - The present invention relates to a thiazole compound as a peroxisome proliferator activated receptor δ (PPARδ) activator or pharmaceutically acceptable salts thereof, and a pharmaceutical composition, a functional cosmetic composition, a health food, health beverages, a food additive and animal feeds containing the same. | 08-02-2012 |
| 20120226049 | METHOD FOR PRODUCING 5-(AMINOMETHYL)-2-CHLOROTHIAZOLE - A method for producing 5-(aminomethyl)-2-chlorothiazole, which comprises the step of mixing a compound represented by formula (2): | 09-06-2012 |
| 20120232284 | Polymorph of a Pharmaceutical - A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed. | 09-13-2012 |
| 20140221666 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 08-07-2014 |
| 20150011775 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS - The present application provides for a compound of Formula I, | 01-08-2015 |
| 20150368237 | Heteroarylpiperidine and - piperazine derivatives as fungicides - Heteroarylpiperidine and -piperazine derivatives of the formula (I) | 12-24-2015 |
| 20160185792 | METHOD FOR THE PURIFICATION OF EPOTHILONES VIA CRYSTALLIZATION - The present invention provides a new method of separating epothilones from one another that can be used on an industrial scale for the selective enrichment of epothilone and to provide a crystalline solid of enhanced purity, which can be used for the production of pharmaceutical preparations without using normal or reverse-phase chromatography or any energy input via distillation apparatus, wherein the new method comprises the steps:
| 06-30-2016 |
| 20160185793 | METHOD FOR THE PURIFICATION OF EPOTHILONES VIA CRYSTALLIZATION - The present invention provides a new method of separating epothilones from one another that can be used on an industrial scale for the selective enrichment of epothilone and to provide a crystalline solid of enhanced purity, which can be used for the production of pharmaceutical preparations without using normal or reverse-phase chromatography or any energy input via distillation apparatus, wherein the new method comprises the steps:
| 06-30-2016 |
| 548205000 | Nitrogen attached indirectly to the thiazole ring by nonionic bonding | 5 |
| 20090299073 | Process for the Manufacture of Epoxybutanol Intermediates - Disclosed is a process for the manufacture of a Compound of formula (I) wherein Hal represents fluoro or chloro, and R | 12-03-2009 |
| 20110087030 | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole - A new technical process for preparation of enantiomerically pure antifungal compounds of formula I by resolution of the racemates has been disclosed. | 04-14-2011 |
| 20110172434 | DERIVATIVES OF HETEROCYCLES WITH 5 MEMBERS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS - The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) | 07-14-2011 |
| 20110313170 | Fluorination of Aromatic Ring Systems - This disclosure relates to reagents and methods useful in the synthesis of aryl fluorides, for example, in the preparation of | 12-22-2011 |
| 20150031894 | NOVEL ORGANIC COMPOUND - The present invention provides an organic compound to be used in an electrochromic device. The organic compound has excellent oxidation-reduction repeating characteristics and shows high transparency in the bleached state without showing light absorption in the visible light region. The organic compound has a structure represented by Formula [1] according to Claim | 01-29-2015 |
